Current Opinion in Gastroenterology

Article	Citations
The utility of liver biopsy in 2020	76
Cancer-associated fibroblasts in cholangiocarcinoma	42
Panorama of mediators in postpancreatitis diabetes mellitus	39
Gaining resilience and reducing stress in the age of COVID-19	34
Metabolic dysfunction-associated fatty liver disease: a year in review	33
Breastfeeding and the developmental origins of mucosal immunity: how human milk shapes the innate and adaptive mucosal immune systems	30
New targets in inflammatory bowel disease therapy: 2021	30
Peutz-Jeghers syndrome	30
Radiation enteritis: from diagnosis to management	29
Update on chronic intestinal pseudo-obstruction	29
Gut microbiota and sepsis: from pathogenesis to novel treatments	26
Recent insights into trace element deficiencies: causes, recognition and correction	26
Cholangiocarcinoma in patients with primary sclerosing cholangitis	25
Molecular classification of cholangiocarcinoma	25
The burden of cost in inflammatory bowel disease: a medical economic perspective	23
Opioid-induced esophageal dysfunction	22
The gut microbiome as a predictor of low fermentable oligosaccharides disaccharides monosaccharides and polyols diet efficacy in functional bowel disorders	21
Role of gut–kidney axis in renal diseases and IgA nephropathy	20
Refeeding syndrome: update and clinical advice for prevention, diagnosis and treatment	19
Autoimmune pancreatitis type 2	19
Protein-losing enteropathy	19
Early detection of pancreatic cancer	18
Advances in the treatment of gastric cancer: 2020–2021	18
Diagnosis and management of Clostridioides difficile infection in patients with inflammatory bowel disease	18
The prevention of gastric cancer by Helicobacter pylori eradication	18

Primary biliary cholangitis: pathogenic mechanisms	18
Diabetes in chronic pancreatitis: risk factors and natural history	17
Cancer cachexia: a multifactoral disease that needs a multimodal approach	16
Why antibiotics should not be used to treat Shiga toxin-producing Escherichia coli infections	16
Gastrointestinal symptoms in COVID-19: the long and the short of it	16
New systemic agents for hepatocellular carcinoma: an update 2020	15
Tracking COVID-19 via sewage	15
Diet and cancer of the esophagus and stomach	15
Gastroparesis and functional dyspepsia: different diseases or different ends of the spectrum?	15
Immune contexture of cholangiocarcinoma	15
Intravenous fluid resuscitation in the management of acute pancreatitis	14
Integration of telemedicine into clinical practice for inflammatory bowel disease	14
Faecal microbiota replacement to eradicate antimicrobial resistant bacteria in the intestinal tract – a systematic review	13
Can SARS-CoV-2 be transmitted via faeces?	13
Robotics in flexible endoscopy: current status and future prospects	13
Endoscopic eradication therapy for Barrett's oesophagus: state of the art	13
Primary biliary cholangitis: treatment	13
Endoscopic diagnosis and management of gastric subepithelial lesions	12
Approaches to diet therapy for eosinophilic esophagitis	12
Bone loss in patients with inflammatory bowel disease: cause, detection and treatment	12
Advances in cirrhotic cardiomyopathy	12
Severe acute respiratory syndrome coronavirus-2-associated cholangiopathies	12
EsoFLIP for esophageal dilation: proposed advantages	12
Hepatic manifestations of cystic fibrosis	11
The impact of inflammatory bowel disease on women's lives	11
Advancing flexible endoscopy to natural orifice transluminal endoscopic surgery	11
Mesenchymal stem cell therapy for liver disease: current status and future perspectives	11
The role of bariatric surgery in the management of nonalcoholic steatohepatitis	11
The importance of anal cancer screening and high-resolution anoscopy to gastroenterology practice	11
Dysregulated lipid metabolism in colorectal cancer	11
The rise of antibiotic resistance in Campylobacter	11
Social media in inflammatory bowel disease: the patient and physician perspective	10
Distinguishing diabetes secondary to pancreatic diseases from type 2 diabetes mellitus	10
Diet and carcinogenesis of gastric cancer	10
Cellular senescence in the cholangiopathies	9
Coronavirus disease-2019: implications for the gastroenterologist	9
Advances in the treatment of biliary tract cancers	9
Advances in the treatment of gastric cancer	9
The potential of microbiome replacement therapies for Clostridium difficile infection	9
Immunotherapy in cholangiocarcinoma	9
The future of telemedicine and wearable technology in IBD	9
Diet as a treatment for inflammatory bowel disease: is it ready for prime time?	8
Noninvasive strategies for colorectal cancer screening: opportunities and limitations	8
Single-use duodenoscopes: where are we and where are we going?	8
Host immune interactions in chronic inflammatory gastrointestinal conditions	8
Proton pump inhibitors: misconceptions and proper prescribing practice	8
Current endoscopic approaches to biliary strictures	8
Noninvasive assessment oesophageal varices: impact of the Baveno VI criteria	8
Novel treatment options for acute hepatic porphyrias	8
Diabetes and pancreatic cancer: recent insights with implications for early diagnosis, treatment and prevention	7

Signatures in drug-induced liver injury	7
Small bowel radiology	7
Macronutrients, microbiome and precision nutrition	7
Fatigue in inflammatory bowel disease: a problematic ailment	7
How to advise patients on the risk of chronic proton pump inhibitor therapy	7
Neoadjuvant therapy in pancreatic cancer: a review and update on recent trials	7
Dietary interventions and irritable bowel syndrome – what really works?	7
Multidisciplinary management of perianal Crohn's disease	7
Mechanisms of autoimmune hepatitis	7
Optimal inflammatory bowel disease management during the global coronavirus disease 2019 pandemic	7
Macrophages in cholangiopathies	7
The treatment approach to inflammatory bowel disease in 2020	7
Type 3 autoimmune pancreatitis (immune checkpoint inhibitor-induced pancreatitis)	7
Celiac disease: clinical update	7
The role of magnetic sphincter augmentation in the treatment of gastroesophageal reflux disease	7
Autoimmune hepatitis: from immunopathogenesis to diagnostic and therapeutic innovation	6
Should high-fiber diets be recommended for patients with inflammatory bowel disease?	6
Refractory coeliac disease: what should we be doing different?	6
Duodenal chemosensory system: enterocytes, enteroendocrine cells, and tuft cells	6
Management of refractory inflammatory bowel disease	6
Complications of chronic pancreatitis in children	6
Third space endoscopy: the future of treating gastrointestinal dysmotility	6
Early detection of pancreatic cancer: current state and future opportunities	6
Management of regurgitation in patients with gastroesophageal reflux disease	6
Statins for treatment of chronic liver disease	6
When is parenteral nutrition indicated in the hospitalized, acutely ill patient?	6
Impact of gastroesophageal reflux disease on idiopathic pulmonary fibrosis and lung transplant recipients	6
Novel treatments for alcoholic hepatitis	6
Endoscopic methods for the detection and treatment of gastric cancer	6
Magnetic sphincter augmentation versus fundoplication for gastroesophageal reflux disease: pros and cons	6
Coagulation testing and management in liver disease patients	6
Acute-on-chronic liver failure: update on pathogenesis, therapeutic targets, predictive models, and liver transplantation	6
Role of albumin in the treatment of decompensated liver cirrhosis	6
Molecular targets and the use of biologics in the management of small bowel fibrosis in inflammatory bowel disease	6
Impact of bariatric surgery on gastroesophageal reflux disease and esophageal motility	6
Genetically engineered animal models of biliary tract cancers	6
Precision medicine: how multiomics will shape the future of inflammatory bowel disease?	5
Nutritional consequences of bariatric surgery – prevention, detection and management	5
The role of the allergist in the management of eosinophilic esophagitis	5
Drug-induced bile duct injury: new agents, new mechanisms	5
Demographics and risk factors for pediatric recurrent acute pancreatitis	5
Comparative efficacy trials in inflammatory bowel disease: current and future implications for practice	5
Advances in chronic intestinal failure management and therapies	5
The natural history of alcohol-related liver disease	5
The bi-directional role of the gut–brain axis in inflammatory and other gastrointestinal diseases	5
Hepatitis E virus: has anything changed?	5
Positioning biologics and small molecules in the management of moderate to severe ulcerative colitis	5
Bile acids, bile pigments and colorectal cancer risk	5
Esophageal afferent innervation and its role in gastro-esophageal reflux disease symptoms	5
Evaluation of very early-onset inflammatory bowel disease	5
Positioning biologics in the management of moderate to severe Crohn's disease	5
The gut-liver axis in cholangiopathies: focus on bile acid based pharmacological treatment	5
Probiotics in irritable bowel syndrome and inflammatory bowel disease: review of mechanisms and effectiveness	4
Painful chronic pancreatitis - new approaches for evaluation and management	4
Implantation of transjugular intrahepatic portosystemic shunt (TIPS): indication and patient selection	4
Interventional endoscopic ultrasound	4
Breath testing for the diagnosis of pancreatic disease	4
A review of deep learning and radiomics approaches for pancreatic cancer diagnosis from medical imaging	4
Recent insights on functional heartburn and reflux hypersensitivity	4
Stem-cell-derived models: tools for studying role of microbiota in intestinal homeostasis and disease	4
Role of the gut–skin axis in IgE-mediated food allergy and atopic diseases	4
Endoscopic simulators: training the next generation	4
The role of the colonic microbiota and bile acids in colorectal cancer	4
Advances in the genetics of nonalcoholic fatty liver disease	4
Cryptogenic multifocal ulcerating stenosing enteritis and other under-recognised small bowel inflammatory enteropathies	4
Updated strategies in the management of acute variceal haemorrhage	4
Mucosal immunity in primary sclerosing cholangitis: from the bowel to bile ducts and back again	4
Practical insights into stomas in inflammatory bowel disease: what every healthcare provider needs to know	4
Ileo-colonic lymphoma: presentation, diagnosis, and management	4
Routine disaccharidase testing: are we there yet?	4
Updates in artificial intelligence in gastroenterology endoscopy in 2020	4
Implications of Paneth cell dysfunction on gastrointestinal health and disease	4
Precision medicine for pancreatic diseases	4
Endohepatology – current status	4
Gastroparesis	4
Management of the patient with esophagogastric junction outflow obstruction	3
Updates in functional dyspepsia and bloating	3
Cholangioscopy for biliary diseases	3
Mucosal defense: gastroduodenal injury and repair mechanisms	3
Coronavirus disease 2019 and the liver	3

The debate in the diagnosis of coeliac disease – time to go ‘no-biopsy’?	3
Point of care diagnostics for Cryptosporidium: new and emerging technologies	3
The management of the hospitalized ulcerative colitis patient: the medical-surgical conundrum	3
Integrating new and emerging therapies into inflammatory bowel disease clinical practice	3
Approach to the patient with infectious colitis: clinical features, work-up and treatment	3
Bile acid diarrhea – as bad as it gets?	3
Newly identified genetic variants associated with idiosyncratic drug-induced liver injury	3
Inflammatory bowel disease in underserved populations: lessons for practice	3
Innate and adaptive immunity in celiac disease	3
Nutrition and diet in inflammatory bowel disease	3
Metabolic dysfunction and nonalcoholic fatty liver disease risk in individuals with a normal body mass index	3
Small intestinal bacterial overgrowth: current update	3
Role of endoscopic ultrasonography guided fiducial marker placement in gastrointestinal cancer	3
Management of upper gastrointestinal symptoms in patients with autoimmune gastritis	3
Postoperative Crohn's disease management	3
Clinical insights into drug-associated pancreatic injury	3
Bile acids as metabolic regulators: an update	3
Solitary rectal ulcer syndrome	3
Gastroduodenal injury and repair: novel targets for therapeutic intervention	2
Flexible endoscopic strategies for the difficult esophageal stricture	2
How provocative tests in addition to wet swallows during high-resolution manometry can direct clinical management	2
Synthetic human livers for modeling metabolic diseases	2
Radiofrequency ablation for the management of pancreatic mass lesions	2
Sarcopenia in cirrhosis: epidemiology, diagnosis, management and prognosis	2
Expanding indications for pancreatic islet cell transplantation	2
Role of mast cells in eosinophilic esophagitis	2
Refractory eosinophilic esophagitis: what to do when the patient has not responded to proton pump inhibitors, steroids and diet	2
Small bowel obstruction: what a gastroenterologist needs to know	2
Cleaning up alpha-1 antitrypsin deficiency related liver disease	2
In vitro models to study Clostridioides difficile infection: current systems and future advances	2
Clostridium difficile in inflammatory bowel disease	2
Esophageal adenocarcinoma phenotypes and risk factors	2
Clinical nutrition for the gastroenterologist: bedside strategies for feeding the hospitalized patient	2
Neurological disorders and small bowel dysmotility	2
Treatment for eosinophilic esophagitis	2
The gut virome in health and disease: new insights and associations	2
Best techniques for endoscopic ampullectomy	2
The use of ultrasound in colonic and perianal diseases	2
The vermiform cecal appendix, expendable or essential? A narrative review	2
Recent developments in antimicrobial therapy for gastrointestinal infections	2
Environmental factors associated with gastric carcinogenesis	2
Percutaneous endoscopic jejunostomy: when, how, and when to avoid it	2
Updates in the understanding and management of diverticular disease	2
The spectrum of diabetes in acute and chronic pancreatitis	2
Clinical and translational markers of severity and prognosis in chronic pancreatitis	2
Consortium for the study of chronic pancreatitis, diabetes, and pancreatic cancer: achievements and future directions	2
Artificial intelligence in digestive endoscopy: recent advances	2
Editorial: food, nutrition and the microbiome in health and disease	2